AYTU BIOPHARMA INC (AYTU)

US0547548588 - Common Stock

2.9043  +0.06 (+2.26%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
Revenue
98.49M107.40M96.70M65.60M27.60M
Cost Of Goods
36.21M40.80M44.40M36.40M7.60M
Gross Profit
62.28M66.60M52.30M29.20M20.10M
Operating Expenses
66.70M78.00M86.70M67.50M40.90M
Research and Development
2.45M4.10M12.70M5.60M1.70M
Selling, General, and Administrative Expenses
60.48M70.10M69.90M55.80M34.80M
Operating Income
-4.42M-11.40M-34.40M-38.20M-20.90M
Interest Income/Expense
-9.65M0.00-800.00K-2.10M-2.60M
Other Income/Expense
N/A4.79M1.60M4.50MN/A
Non Recurring Items
N/A-5.70M-75.30M-22.20M9.90M
Income Before Taxes
-17.17M-17.10M-108.90M-58.00M-13.60M
Income Tax
828.00K0.00-100.00K300.00KN/A
Net Income
-18.00M-17.10M-108.80M-58.30M-13.60M
EBITDA
4.30M-2.58M-24.15M-29.00M-14.65M
 
Per Share Data
EPS Diluted Total Ops
-4.05-5.18-72.53-72.87-68.00
Non GAAP EPS
-4.04-5.03-76.20-3.26-5.00
 
Statistics
Gross Profit Margin
63.24%62.01%54.08%44.51%72.83%
Profit Margin
-18.28%-15.92%-112.51%-88.87%-49.28%
Operating Profit Margin
-4.48%-10.61%-35.57%-58.23%-75.72%

All data in USD

Charts